We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NVMI:NASDAQNova Ltd. Analysis

Data as of 2026-05-23 - not real-time

$503.49

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Nova Ltd. delivered a record first‑quarter 2026, posting ~10% revenue growth, a 57% gross margin and a 30% operating margin, while EPS is expected to climb to $12.94 from $7.99 a year ago. Management highlighted strong demand from advanced DRAM, advanced packaging and gate‑all‑around applications, which underpins the bullish technical backdrop – the price sits above the 20‑day SMA (≈$507) and the 50‑day SMA (≈$490), with a bullish trend direction and increasing volume. However, the stock trades at a **PE of 63** versus an industry average of ~39, and a DCF‑derived fair value of only $86.7, indicating a substantial valuation premium. The MACD shows a bearish histogram, and with a beta above 2.5 and 30‑day volatility exceeding 60%, price swings could be sharp. Recent news of a record quarter and market‑share gains fuels short‑term optimism, but the high valuation and geopolitical exposure to Taiwan, the U.S., and China temper long‑term confidence.
Overall, the company’s growth fundamentals are strong, but investors should weigh the overvaluation and elevated risk profile against the upside potential from AI‑driven semiconductor demand.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Record Q1 revenue and margin expansion
  • Price above key moving averages with bullish trend
  • Momentum from pre‑market price gains

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Premium valuation relative to DCF and peers
  • High beta and volatility may cause price swings
  • Sustained demand from AI‑related semiconductor segments

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong growth outlook in advanced packaging and GAA technologies
  • Robust operating cash flow and free cash flow generation
  • Strategic position in a high‑growth semiconductor equipment market

Key Metrics & Analysis

Financial Health

Revenue Growth10.30%
Profit Margin29.21%
P/E Ratio63.0
ROE22.25%
ROA8.40%
Debt/Equity57.67
P/B Ratio12.1
Op. Cash Flow$217.1M
Free Cash Flow$122.4M
Industry P/E39.5

Technical Analysis

TrendBullish
RSI50.4
Support$462.77
Resistance$565.00
MA 20$506.76
MA 50$489.89
MA 200$382.97
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$86.70
Target Price$597.63
Upside/Downside18.70%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.63
Volatility61.08%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.